Assessing the Barriers to Engaging Challenging Populations in Disease Management Programs
Tóm tắt
Disease management has gained popularity as a way to improve health status and control of chronic illness through the use of risk stratification, targeted nurse outreach, telephonic nurse advice, and evidence-based guidelines in managing illness. Disease management programs have been successfully implemented by commercial insurers and managed care plans, as well as in Medicare and state Medicaid programs. Although evidence regarding cost savings is inconsistent, it appears that disease management programs do impact health status and quality of care, and improve self-management among the chronically ill. Disease management programs can be customized to meet the needs of vulnerable subpopulations. This article explores the barriers to dealing with chronic illness and other factors faced by disease management programs for Medicaid populations. Barriers to participation and success in disease management for Medicaid beneficiaries are apparent due to lack of access to translation and interpretation services; difficulty with community outreach; achieving buy in from providers and beneficiaries; problems with housing; difficulties accessing primary and specialty care; problems with the availability of pharmacy, durable medical equipment, and other support services; as well as difficulties with Medicaid eligibility and ‘churn’. In order to create a successful disease management program that positively impacts health status, utilization, and cost, it is necessary to consider all of these barriers when designing an intervention for Medicaid beneficiaries. Some of the innovative ways to handle the difficulties of dealing with Medicaid or other low-income populations with special healthcare needs include expanded interpretation and translation activities, extensive community outreach to patients and safety net providers such as clinics and public hospitals, providing support services related to non-medical problems experienced by enrollees, providing understandable written and verbal instructions and training related to health education and medication adherence, as well as efforts to track and maintain contact with eligible and enrolled individuals. Disease management programs can be successful in saving money and improving health in Medicaid populations. However, they must be carefully designed with the specific state Medicaid program and should target the needs of the state’s beneficiaries.
Tài liệu tham khảo
Villagra VG. Perspective: integrating disease management into the outpatient delivery system during and after managed aare. Health Aff 2004 May; W4: 281–3
Geyman JP. Disease management: panacea, another false hope, or something in between?. Ann Fam Med 2007 May/June; 5(3): 257–260
Holmes AM, Ackermann RD, Zillich AJ, et al. The net fiscal impact of a chronic disease management program: Indiana Medicaid. Health Aff 2008; 27(3): 855–64
Mattke S, Seid M, Ma S. Evidence for the effect of disease management: is $1 billion a year a good investment?. Am J Manag Care 2007 Dec; 13(12): 670–6
Rossiter LF, Whitehurst-Cook MY, Small RE, et al. The impact of disease management on outcomes and cost of care: a study of low-income asthma patients. Inquiry 2000; 37(2): 188–202
Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care 1999 Jan; 37(1): 5–14
Afifi AA, Morisky DE, Kominski GF, et al. Impact of disease management programs on health care utilization: evidence from the ‘Florida: A Healthy State (FAHS)’ Medicaid program. Prev Med 2007 Jun; 44(6): 547–53
Thiebaud P, Demand M, Wolf SA, et al. Impact of disease management on utilization and adherence with drugs and tests. The case of diabetes treatment in the Florida: A Healthy State (FAHS) program. Diabetes Care 2008; 31(9): 1717–22
Linden A, Berg GD, Wadhwa S. Evaluation of a Medicaid asthma disease management program. Dis Manag 2007 Oct; 10(5): 266–72
Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA 2002 Oct; 288(15): 1909–14
White C, Fisher C, Mendelson D, et al. State Medicaid disease management: lessons learned from Florida. 2005 Mar [online]. Available from URL: http://www.avalerehealth.net/research/docs/Duke_DM-Florida.pdf [Accessed 2008 Jun 28]
Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA 2002 Oct; 288(14): 1775–9
California HealthCare Foundation. Medi-Cal facts and figures: a look at California’s Medicaid program. 2007 May [online]. Available from URL: http://www.chcf.org/documents/policy/MediCalFactsAndFigures2007.pdf [Accessed 2008 Jun 28]
Druss BG, Marcus SC, Olfson S, et al. Comparing the national economic burden of five chronic conditions. Health Aff 2001 Jun; 20(6): 233–41
Feinberg E, Swartz K, Zaslavsky AM, et al. Language proficiency and the enrollment of Medicaid-eligible children in publicly funded health insurance programs. Matern Child Health J 2002 Mar; 6(1): 5–18
Tobias C, Maisels L, Andrew J. How health plans identify and serve Medicaid special needs populations. Health and Disability Working Group. Boston University School of Public Health. 2000 Jun [online]. Available from URL: http://www.bu.edu/hdwg/pdf/reports/HPlanbackground.pdf [Accessed 2008 Jun 21]
The Henry J. Kaiser Family Foundation. State health facts [online]. Available from URL: http://www.statehealthfacts.org [Accessed 2008 Jun 28]
Wagner EH, Austin BT, Von Korff M. Improving outcomes in chronic illness. Manag Care Q 1996 Spring; 4(2): 12–25
Chin M, Drum M, Guillen M. Improving and sustaining diabetes care in community health centers with the Health Disparities Collaborative. Med Care 2007 Dec; 45(12): 1135–43
Maizlish NA, Shaw B, Hendry K. Glycemic control in diabetic patients served by community health centers. Am J Med Qual 2004; 19(4): 172–9
Chin MH, Cook S, Drum ML, et al. Improving diabetes care in Midwest community health centers with the Health Disparities Collaborative. Diabetes Care 2004; 27(1): 2–8
McCullough DK, Price MJ, Hindmarsh M, et al. A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract 1998; 1(1): 12–22
McManus M, Kelly R, Flint S. The adequacy of physician reimbursement for pediatric care under Medicaid. Pediatrics 1991; 87(6): 909–20
Bindman A, Yoon J, Grumbach K. Physician participation in Medi-Cal, 2001. Medi-Cal Policy Institute; California HealthCare Foundation. 2003 Jun [online]. Available from URL: http://www.chcf.org/documents/policy/MediCalDisabilitiesMMCvsFFS.pdf [Accessed 2008 Jun 28]
Master RJ, Taniguchi C. Medicare, Medicaid, and people with disability. Health Care Financ Rev 1996; 18(2): 91–7
Chimento L, Forbes M, Sander A, et al. Medi-Cal beneficiaries with disabilities: comparing managed care with fee-for-service systems. California HealthCare Foundation Issue Brief 2005 Aug [online]. Available from URL: http://www.chcf.org/documents/policy/MediCalDisabilitiesMMCvsFFS.pdf [Accessed 2008 Jun 28]
Bindman AB, Chattopadhyay A, Osmond DH, et al. The impact of Medicaid managed care on hospitalizations for ambulatory care sensitive conditions. Health Serv Res 2005; 40(1): 19–38
Roohan PJ, Butch JM, Anarella JP. Quality measurement in Medicaid managed care and fee-for-service. Am J Med Qual 2006; 21(3): 185–91
American Academy of Pediatrics. AAP Medicaid reimbursement survey, 2007/08: final report. 2008 Apr [online]. Available from URL: http://www.aap.org/research/medreimpdf0708/49state_DC.pdf [Accessed 2008 Jun 28]
Linden A. Use of the pre-post method to measure cost savings in disease management: issues and implications. Dis Manag Health Outcomes 2007; 15(1): 13–8
Patrie K, Stickles JD, Turpin RS, et al. Diabetes disease management in Medicaid managed care: a program evaluation. Dis Manag 2006; 9(3): 144–56
Short PF, Graefe DR. Battery-powered health insurance? Stability in coverage of the uninsured. Health Aff 2003; 22(6): 244–55
Brazil K, Cloutier MM, Tennen H, et al. A qualitative study of the relationship between clinician attributes, organization, and patient characteristics on implementation of a disease management program. Dis Manag 2008 Apr; 11(2): 129–37
MacStravic S. The challenge of participation in disease management. Dis Manag 2007 Nov; 10(5): 247–51
Lynch W, Chen CY, Bender J, et al. Documenting participation in an employer-sponsored disease management program: selection, exclusion, attrition, and active engagement as possible metrics. J Occup Environ Med 2006 May; 48(5): 447–54
Dickson M, Plauschinat CA. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment. Ethn Dis 2008; 18(2): 204–9
Horswell R, Butler MK, Kaiser M, et al. Disease management programs for the underserved. Dis Manag 2008; 11(3): 145–52
Institute of Medicine (US) Committee on Health Care for Homeless People. Homelessness, health and human needs. Washington (DC): National Academies Press, 1988
Gary TL, McGuire M, McCauley J, et al. Racial comparisons of health care and glycemic control for African American and White diabetic adults in an urban managed care organization. Dis Manag 2004; 7(1): 25–34
Kominski GF, Morisky DE, Afifi AA, et al. The effect of disease management on utilization of services by race/ethnicity: evidence from the Florida Medicaid Program. Am J Manag Care 2008 Mar; 14(3): 168–72